0001290929-23-000007.txt : 20230130 0001290929-23-000007.hdr.sgml : 20230130 20230130120143 ACCESSION NUMBER: 0001290929-23-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230127 FILED AS OF DATE: 20230130 DATE AS OF CHANGE: 20230130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolf James G. CENTRAL INDEX KEY: 0001419248 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 23566217 MAIL ADDRESS: STREET 1: 105, FLYWAY DRIVE CITY: KIAWAH ISLAND STATE: SC ZIP: 29455 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2023-01-27 0 0000316253 ENZO BIOCHEM INC ENZ 0001419248 Wolf James G. 105, FLYWAY DRIVE KIAWAH ISLAND SC 29455 0 0 1 0 Common Stock, $0.01 par value 2023-01-27 4 P 0 11800 1.4 A 4090000 D Common Stock, $0.01 par value 418500 I See Footnote The 418,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse, 110,000 shares owned directly by the Reporting Person's sibling and 170,500 shares owned directly by adult children of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any. James G. Wolf 2023-01-30